News Center
Escape the city hustle, climb to the peak for greatness — Le'an Pharma and its subsidiary Entai 2026 team-building trip to Mount Huangshan was a resounding success.
From 2026 to 3, Lian Pharmaceutical and its subsidiary Entai held a Huangshan team-building event themed "Climb High, Forge Glory." The event aimed to strengthen company cohesion and inspire employees to face challenges with courage and determination. From the thrilling Jiaxi River rafting to the historic tour of Hongcun Village, from Huangshan's unique pine trees and rock formations to the welcoming pine standing resilient in wind and rain, the three-day, two-night journey was filled with challenges and moving moments, showcasing the team's unity, collaboration, and perseverance.
Company launches new project; strategic partnership established with Sichuan Jisheng Biopharmaceuticals.
ENTAI and Sichuan Jisheng Biopharmaceutical Co., Ltd. have officially signed a cooperation agreement to jointly develop custom peptide products. This partnership marks a strategic advancement in our pharmaceutical intermediates portfolio, leveraging combined strengths to create high-value-added peptides that meet the global demand for customized peptide solutions from pharmaceutical clients.
Company fully upgrades import and export compliance control system
To comply with new international trade regulations, the company has implemented an advanced compliance management system to enhance control over hazardous goods declaration, document verification, and logistics tracking.
2026 Shanghai International Chemical Industry Exhibition participation plan officially announced
ENTAI TRADING confirms participation in the International Chemical Exhibition to be held in Shanghai in 2026 7, where we will showcase our latest product lines and supply chain capabilities.
Food Additive Series Adds New Compliant Certified Products
The company's food additive product line now includes products certified under multiple international standards, including FCC and GB2760, further meeting the compliance needs of global food customers.
The company was awarded the 2025 Outstanding Export Enterprise title.
ENTAI TRADING was honored as the 2025 Outstanding Export Enterprise for its exceptional export performance and professional service quality, recognizing our years of dedication to the international market.
Expansion of pharmaceutical intermediate product line with multiple new high-purity offerings
Our pharmaceutical intermediate product line has been significantly expanded with several new high-purity intermediates, achieving purity levels above 99.9% to meet the needs of premium pharmaceutical clients.
The company attended the 2025 Canton Fair and secured a wealth of orders.
Suzhou Layuan Pharmaceutical Chemistry Technology Co., Ltd. participated in the 135 Canton Fair, established cooperation intentions with clients from Southeast Asia, the Middle East, Europe, and other regions, and signed multiple long-term supply agreements.
Solvent Additive Series Certified Under EU REACH Regulations
The company's solvent and additive product series has officially received EU REACH certification, confirming that our products meet EU standards and laying the foundation for expansion into the European market.